SEC Filing Document

Company: Berto Acquisition Corp. II
Ticker: GUAC
CIK: 2081515
Filing Type: S-1
Document Type: EX-1.1
Date Filed: 2026-04-27
Accession Number: 0001829126-26-003952
Exchange: 
SIC Code: 6770
SIC Description: Blank Checks
URL: https://www.sec.gov/Archives/edgar/data/2081515/000182912626003952/bertoacquisition2_ex1-1.htm

Chunk 11 of 22
Word Count: 1462
Character Count: 9387

Document Content:

3.6 Affiliated Transactions. 3.6.1 Business Combinations. In the event the Company seeks to consummate a Business Combination with any entity that is affiliated with any Insider, the Company, or a committee of its independent directors, shall obtain (i) an opinion from an independent investment banking firm that is a member of FINRA, or from an independent accounting firm, that the Business Combination is fair to the Company from a financial point of view and (ii) a majority of the Company’s disinterested and independent directors (if there are any) approve such transaction. 3.6.2 Compensation to Insiders. Except as disclosed in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus, the Company shall not pay any of the Insiders or any of their affiliates any fees or compensation from the Company, for services rendered to the Company prior to, or in connection with, the consummation of a Business Combination. 3.7 [Reserved.]

3.8 Reports to the Representative. For a period of five (5) years from the Effective Date or until such earlier time upon which the Company is required to be liquidated or is no longer required to file reports under the Exchange Act, the Company will furnish to the Representative and its counsel copies of such financial statements and other periodic and special reports as the Company from time to time furnishes generally to holders of any class of its securities, and promptly furnish to the Underwriters (i) a copy of each periodic report the Company shall be required to file with the Commission, (ii) a copy of every press release and every news item and article with respect to the Company or its affairs that was released by the Company, (iii) a copy of each Current Report on Form 8-K or Schedules 13D, 13G, 14D-1 or 13E-4 received or prepared by the Company, (iv) two (2) copies of each registration statement filed by the Company with the Commission under the Act, and (v) such additional documents and information with respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably request; provided the Representative shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative and its counsel in connection with the Representative’s receipt of such information. Documents filed or furnished with the Commission pursuant to its EDGAR system shall be deemed to have been delivered to the Representative pursuant to this Section 3.8.

3.9 Transfer Agent and Warrant Agent. For a period of five (5) years following the Effective Date or until such earlier time upon which the Company is required to be liquidated (or, in the case of the Warrants, until the Business Combination Closing), the Company shall retain a transfer agent and warrant agent acceptable to the Representative. In each case, Continental is acceptable to the Representative.

3.10 Payment
of Expenses. The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if any, to the extent not
paid at the Closing Date, all Company expenses incident to the performance of the obligations of the Company under this Agreement,
including but not limited to (i) the Company’s legal and accounting fees and disbursements; (ii) the preparation, printing,
filing, mailing and delivery (including the payment of postage with respect to such mailing) of the Registration Statement, the Sale
Preliminary Prospectus and the Prospectus, including any pre- or post-effective amendments or supplements thereto, and the printing
and mailing of this Agreement and related documents, including the cost of all copies thereof and any amendments thereof or
supplements thereto supplied to the Underwriters in quantities as may be required by the Underwriters; (iii) fees incurred in
connection with conducting background checks of the Company’s management team, up to a maximum of $3,000 per person; (iv) the
preparation, printing, engraving, issuance and delivery of the Units, the Ordinary Shares and the Warrants included in the Units,
including any transfer or other taxes payable thereon; (v) filing fees incurred in registering the Offering with FINRA and the
reasonable fees of counsel of the Underwriters (such legal fees not to exceed $15,000) in connection therewith and including,
without limitation, fees associated with qualifying the Offering under the “Blue Sky” laws of any states specified by
the Representative; (vi) fees, costs and expenses incurred in listing the Securities on Nasdaq or such other stock exchanges as the Company

and the Underwriters together determine; (vii) all fees and disbursements of the transfer and warrant agent; (viii) all of the Company’s expenses associated with “due diligence” and “road show” meetings arranged by the Representative and any presentations made available by way of a net roadshow, including without limitation, trips for the Company’s management to meet with prospective investors, all travel, food and lodging expenses associated with such trips incurred by the Company or such management; and (ix) all other documented out-of-pocket costs and expenses customarily borne by an issuer incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this Section 3.10. The Representative, on behalf of itself and the Underwriters, hereby acknowledges and agrees that the underwriting discount set forth in this Agreement (including the upfront purchase price discount set forth in Section 1.1.1 and the Deferred Underwriting Commission set forth in Section 1.3) has been negotiated to take into full consideration any and all expenses that the Representative and the Underwriters may incur in connection with the Offering, and that such underwriting discount constitutes the sole and exclusive compensation and reimbursement payable to the Representative and the Underwriters in connection with the Offering. Accordingly, the Representative, on behalf of itself and the Underwriters, hereby irrevocably waives any and all rights to seek reimbursement or payment of any expenses, costs, fees or disbursements of any kind from the Company in connection with the Offering upon the consummation thereof, including, without limitation, any non-accountable expense allowance, accountable expense reimbursement or any other payment in respect of expenses. If the Offering is not consummated for any reason (other than a breach by any Underwriters of any of its obligations hereunder, including failure to proceed with preparations for the Offering in good faith), then the Company shall reimburse the Representative in full for their reasonable and documented expenses actually incurred, including, without limitation, reasonable fees and disbursements of counsel to the Underwriters related to FINRA matters, and such expenses, including any costs of counsel to the Underwriters, shall not exceed $25,000 in the aggregate, which amount shall constitute the sole and exclusive remedy of the Underwriters for reimbursement of expenses in the event the Offering is not consummated.

3.11 Application of Net Proceeds. The Company will apply the net proceeds from the Offering and the Warrant Private Placement received by it in a manner consistent in all material respects with the application described under the caption “Use of Proceeds” in the Prospectus.

3.12 Delivery of Earnings Statements to Security Holders. The Company will make generally available to its security holders as soon as practicable an earnings statement (which need not be certified by an independent registered public accounting firm unless required by the Act or the Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Act) covering a period of at least twelve (12) consecutive months beginning after the Effective Date.

3.13 Notice to FINRA.

3.13.1 Notice to the Representative. For a period of sixty (60) days after the date of the Prospectus, in the event any person or entity (regardless of any FINRA affiliation or association) is engaged, in writing, to assist the Company in its search for a Target Business or to provide any other services in connection therewith, the Company will provide the following to the Representative prior to the Business Combination Closing: (i) complete details of all services and copies of agreements governing such services, and (ii) justification as to why the person or entity providing the merger and acquisition services should not be considered a Participating Member with respect to the Offering, as such term is defined in FINRA Rule 5110. The Company also agrees that, if required by law, proper disclosure of such arrangement or potential arrangement will be made in the tender offer documents or proxy statement which the Company will file with the Commission in connection with the Business Combination.

3.13.2 FINRA. The Company shall advise the Representative if it is aware that any 10% or greater shareholder of the Company becomes an affiliate or associated person of a Participating Member.

3.13.3 Broker/Dealer. In the event the Company intends to register as a broker/dealer, merge with or acquire a registered broker/dealer, or otherwise become a member of FINRA, it shall promptly notify FINRA.